Concepedia

Timothy T. Ferng

TT

Statistics

Publications

2

Citations

482

H-Index

2

Active since

2009

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Timothy T. Ferng is an author at Roswell Park Comprehensive Cancer Center specializing in pharmacology, ras signaling, and flt3 inhibitors.

ORCID

Publications per year

2009–2019

2

Publications

2

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia

Christine M. McMahon, Timothy T. Ferng, Jonathan Canaani et al. · Cancer Discovery · 2019 · 437 citations · Full text

, , +16

High-Throughput Screening for Small-Molecule Inhibitors of LARG-Stimulated RhoA Nucleotide Binding via a Novel Fluorescence Polarization Assay

Chris R. Evelyn, Timothy T. Ferng, Rafael J. Rojas et al. · SLAS DISCOVERY · 2009 · 45 citations · Full text

, , +17

1–2 of 2